JP2003262637A - Inspection piece and inspection method - Google Patents

Inspection piece and inspection method

Info

Publication number
JP2003262637A
JP2003262637A JP2002064188A JP2002064188A JP2003262637A JP 2003262637 A JP2003262637 A JP 2003262637A JP 2002064188 A JP2002064188 A JP 2002064188A JP 2002064188 A JP2002064188 A JP 2002064188A JP 2003262637 A JP2003262637 A JP 2003262637A
Authority
JP
Japan
Prior art keywords
water
substance
test
absorbent substrate
labeled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002064188A
Other languages
Japanese (ja)
Inventor
Keisaku Okada
圭策 岡田
Yasuyuki Tanaka
康進 田中
Riyouko Asai
量子 浅井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Priority to JP2002064188A priority Critical patent/JP2003262637A/en
Publication of JP2003262637A publication Critical patent/JP2003262637A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an inspection piece capable of detecting a substance to be inspected with high accuracy, and to provide an inspection method. <P>SOLUTION: The inspection piece contains a water-absorbing substrate 1 which is situated so as to be separated and to which a substance capable of being specifically bonded to the substance to be inspected is immobilized; a water-absorbing substrate 3 to be impregnated with a buffer for development; and a water-absorbing substrate 2 which contains a labeled substance, capable of being specifically bonded to the substance to be inspected and which is used to add a solution to be inspected. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は簡便、迅速に且つ高
精度に被検物質の検出を行い得る検査片及び検査方法に
関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a test piece and a test method capable of detecting a test substance simply, quickly and highly accurately.

【0002】[0002]

【従来の技術】生体中試料等の分析法において、迅速か
つ簡便にその検査を行う方法として、免疫クロマトグラ
フ法が知られている。この方法は、一般に、吸水性基材
表面の任意の領域に被検物質と特異的に結合し得る抗体
を固定化した試験片上で、検出シグナルを得る為の標識
物質を付与した、被検物質と特異的に結合し得る抗体と
被検物質を含む被検液を接触させ、試験片上に形成した
免疫複合体により該被検液中の被検物質の検出を行うも
のである。例えば、以下のようなステップを経る。吸水
性基材上に被検物質と結合し得る抗体を固定化した固相
部を有する試験片の一端に、被検液および被検液中の該
被検物質と結合し得る標識抗体を滴下などして吸収さ
せ、これらの混合物を展開させる。そして、混合により
形成した、標識抗体−被検物質複合体が前記固相部にて
固定化抗体と結合する。固相部にて結合した標識抗体を
測定することにより、被検液中の被検物質を測定するこ
とが出来る。
2. Description of the Related Art An immunochromatographic method is known as a method for rapidly and simply conducting an inspection of an in-vivo sample or the like. This method is generally carried out by adding a labeling substance for obtaining a detection signal on a test piece on which an antibody capable of specifically binding to a test substance is immobilized on an arbitrary region of the surface of a water-absorbing substrate, The test liquid containing the test substance is brought into contact with an antibody capable of specifically binding to, and the test substance in the test liquid is detected by the immune complex formed on the test piece. For example, the following steps are taken. A test solution and a labeled antibody capable of binding to the test substance in the test liquid are added dropwise to one end of a test piece having a solid phase portion on which an antibody capable of binding to the test substance is immobilized on a water-absorbent substrate. Absorb and develop the mixture. Then, the labeled antibody-test substance complex formed by mixing binds to the immobilized antibody in the solid phase portion. By measuring the labeled antibody bound in the solid phase part, the test substance in the test liquid can be measured.

【0003】また、免疫クロマトグラフ法は被検物質の
有無を判定する定性測定のみにとどまらず、固相部に現
れた、標識物質から得られる発色・発光などのシグナル
量を測定することで、被検液中に含まれる被検物質の定
量測定も可能である。
Further, the immunochromatographic method is not limited to qualitative measurement for determining the presence or absence of a test substance, but it is also possible to measure the amount of signal such as coloration and luminescence obtained from the labeling substance, which appears in the solid phase. Quantitative measurement of the test substance contained in the test liquid is also possible.

【0004】しかし、上記の方法では、吸水性基材から
なる試験片に被検液を滴下し、標識抗体との混合物を展
開させる工程において、ピペットまたはスポイトを用い
た被検液の滴下の際に滴下量にばらつきが生じたり、ま
たは標識抗体と被検液との混合状態や濃度分布にばらつ
きが生じたりして、固相部抗体での反応性が一定となら
ず、その結果、含有する被検物質量に応じたシグナル量
を得ることが困難となる。
However, in the above method, in the step of dropping the test solution onto the test piece made of the water-absorbent substrate and developing the mixture with the labeled antibody, the test solution is dropped using a pipette or a dropper. The reactivity of the solid phase antibody is not constant due to variations in the dropping amount, or variations in the mixing state and concentration distribution of the labeled antibody and the test solution, and as a result, it is contained. It becomes difficult to obtain a signal amount according to the amount of the test substance.

【0005】[0005]

【発明が解決しようとする課題】本発明は、高精度に被
検物質を検出することができる検査片及び検査方法を提
供することを目的とする。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a test piece and a test method capable of detecting a test substance with high accuracy.

【0006】[0006]

【課題を解決するための手段】本発明者らは、上記の問
題を解決すべく鋭意研究した結果、免疫クロマトグラフ
法等に用いる検査片において、被検物質と特異的に結合
し得る物質(以下「第1結合物質」ともいう。)を固定
化した吸水性基材1と、展開用緩衝液を含浸させた吸水
性基材3とを分離して位置させ、被検液を吸収させた、
被検物質と特異的に結合し得る標識された物質(以下
「標識第2結合物質」ともいう。)を含有した吸水性基
材2で吸水性基材1と吸水性基材3の間を接触架橋させ
ることで、被検物質量に応じた検出シグナルを得ること
ができることを見出した。すなわち、標識第2結合物質
を含有した吸水性基材2に被検液を滴下し吸収させて飽
和した状態にすると、一定量の被検液を含むこととな
り、また、被検液と標識第2結合物質とが均一に混合し
た状態になる。この吸水性基材2により、第1結合物質
を固定化した吸水性基材1と展開用緩衝液を含浸させた
吸水性基材3との間を接触架橋すると、その時点で液移
動が開始し、被検液と標識第2結合物質は一定の混合状
態または濃度分布で吸水性基材1の第1結合物質を固定
化した領域(固相部)を通過して複合体形成の反応を生
じ、その結果、被検物質量に応じたシグナルが高精度に
得られる。すなわち、本発明は以下の通りである。
Means for Solving the Problems As a result of intensive studies to solve the above problems, the present inventors have found that in a test piece used for immunochromatography or the like, a substance capable of specifically binding to a test substance ( Hereinafter, also referred to as “first binding substance”) and the water-absorbent substrate 1 on which the immobilization buffer solution is impregnated and the water-absorbent substrate 3 impregnated with the developing buffer are positioned separately to absorb the test liquid. ,
A water-absorbing substrate 2 containing a labeled substance capable of specifically binding to a test substance (hereinafter also referred to as “labeled second binding substance”) is provided between the water-absorbing substrate 1 and the water-absorbing substrate 3. It has been found that a detection signal corresponding to the amount of the test substance can be obtained by contact crosslinking. That is, when the test liquid is dropped onto the water-absorbent substrate 2 containing the labeled second binding substance to be absorbed and saturated, a fixed amount of the test liquid is contained, and the test liquid and the labeled first The two-binding substance is in a state of being uniformly mixed. When the water-absorbing substrate 2 on which the first binding substance is immobilized and the water-absorbing substrate 3 impregnated with the developing buffer solution are contact-crosslinked by the water-absorbing substrate 2, liquid transfer starts at that point. Then, the test liquid and the labeled second binding substance pass through the region (solid phase portion) of the water-absorbent substrate 1 on which the first binding substance is immobilized in a constant mixed state or concentration distribution to allow a reaction for complex formation. As a result, a signal corresponding to the amount of the test substance is obtained with high accuracy. That is, the present invention is as follows.

【0007】(1)分離して位置する、被検物質と特異
的に結合し得る物質を固定化した吸水性基材1と展開用
緩衝液含浸用の吸水性基材3、および被検物質と特異的
に結合し得る標識された物質を含有した被検液添加用の
吸水性基材2を含有する検査片。 (2)被検物質と特異的に結合し得る標識された物質の
標識物質が色素で着色した水分散性高分子または金コロ
イドである、上記(1)記載の検査片。 (3)吸水性基材2に被検物質と特異的に結合し得る標
識された物質が乾燥固定化した、上記(1)または
(2)に記載の検査片。 (4)吸水性基材2に血球分離膜を設置した、上記
(1)〜(3)のいずれかに記載の検査片。 (5)被検物質と特異的に結合し得る物質が免疫化学的
成分であり、被検物質と特異的に結合し得る標識された
物質が標識された免疫化学的成分である、上記(1)〜
(4)のいずれかに記載の検査片。 (6)上記(1)〜(5)のいずれかに記載の検査片に
おいて、吸水性基材2に被検液を吸収させた後、展開用
緩衝液を含浸させた吸水性基材3と吸水性基材1を吸水
性基材2で接触架橋する、被検液中の被検物質の検査方
法。
(1) Separately positioned water-absorbent substrate 1 on which a substance capable of specifically binding to a test substance is immobilized, water-absorbent substrate 3 for impregnating a developing buffer solution, and test substance A test piece containing a water-absorbent substrate 2 for adding a test liquid containing a labeled substance capable of specifically binding with. (2) The test piece according to (1), wherein the labeling substance of the labeled substance capable of specifically binding to the test substance is a dye-colored water-dispersible polymer or gold colloid. (3) The test piece according to (1) or (2) above, wherein a labeled substance capable of specifically binding to a test substance is dry-immobilized on the water-absorbent substrate 2. (4) The test piece according to any one of (1) to (3) above, wherein a blood cell separation membrane is installed on the water-absorbent substrate 2. (5) The substance capable of specifically binding to the test substance is an immunochemical component, and the labeled substance capable of specifically binding to the test substance is a labeled immunochemical component, (1) ) ~
The inspection piece according to any one of (4). (6) The test piece according to any one of (1) to (5) above, wherein the water-absorbent substrate 2 is made to absorb a test liquid and then impregnated with a developing buffer solution. A method for inspecting a test substance in a test liquid, which comprises contact-crosslinking the water-absorbent substrate 1 with the water-absorbent substrate 2.

【0008】[0008]

【発明の実施の形態】以下に、本発明を詳細に説明す
る。本発明の検査片または検査方法により検出され得る
被検物質は、免疫化学的反応(抗原抗体反応)、リガン
ド−レセプター結合等の生物学的親和性に基づいて第1
結合物質および標識第2結合物質と結合して複合体を形
成し得るものであれば特に制限されず、例えば、抗原、
抗体、ホルモン、ホルモンレセプター、レクチン、レク
チン結合性糖質、薬物若しくはその代謝物、薬物レセプ
ター、核酸およびそれらの断片等が挙げられるが、抗原
抗体反応により免疫複合体を形成し得るものが好まし
い。サンドイッチイムノアッセイや競合イムノアッセイ
などで測定が行われている被検物質への応用が広く可能
である。例えば、細菌(特に大腸菌O157、サルモネ
ラ、リステリアなどの病原性細菌)、放線菌、酵母、か
び、ウイルス(特にHIV、HBV、HCVなど)など
の微生物またはそれらに対する抗体、あるいは腫瘍マー
カー抗原、相反応性物質、炎症マーカー抗原(特にC反
応性蛋白など)などの臨床診断を目的とした生体試料中
の物質などが挙げられる。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention is described in detail below. The test substance that can be detected by the test strip or the test method of the present invention is the first based on biological affinity such as immunochemical reaction (antigen-antibody reaction) and ligand-receptor binding.
There is no particular limitation as long as it can form a complex by binding to the binding substance and the labeled second binding substance, for example, an antigen,
Examples thereof include antibodies, hormones, hormone receptors, lectins, lectin-binding carbohydrates, drugs or metabolites thereof, drug receptors, nucleic acids and fragments thereof, but those capable of forming an immune complex by an antigen-antibody reaction are preferable. It can be widely applied to test substances that are measured by sandwich immunoassay, competitive immunoassay, and the like. For example, microorganisms such as bacteria (especially Escherichia coli O157, pathogenic bacteria such as Salmonella, Listeria, etc.), actinomycetes, yeasts, fungi, viruses (especially HIV, HBV, HCV, etc.) or antibodies thereto, or tumor marker antigen, phase reaction And substances in biological samples for the purpose of clinical diagnosis, such as active substances and inflammatory marker antigens (especially C-reactive protein).

【0009】被検物質を含有する被検液は、例えば、食
品から抽出した溶液やその培養上清、便懸濁液、血漿、
血清、尿などの液体試料、あるいはこれらを適当な緩衝
液によって希釈してなる希釈液などが挙げられる。
The test liquid containing the test substance is, for example, a solution extracted from food, its culture supernatant, fecal suspension, plasma,
Examples include liquid samples such as serum and urine, and diluents prepared by diluting these with an appropriate buffer solution.

【0010】本発明の検査片は、第1結合物質を固定化
した吸水性基材1と、標識第2結合物質を含有した被検
液添加用の吸水性基材2と、展開用緩衝液含浸用の吸水
性基材3を含有することが必須である。また、本発明の
検査片は、吸水性基材1と吸水性基材3が、吸水性基材
2によって接触架橋され得る程度の間隔で、分離して位
置することが必須である。本明細書において、吸水性基
材1とは、第1結合物質を固定化させる吸水性基材をい
い、吸水性基材2とは、標識第2結合物質を含有させる
被検液添加用の吸水性基材をいい、吸水性基材3とは、
展開用緩衝液含浸用の吸水性基材をいう。
The test piece of the present invention comprises a water-absorbing substrate 1 on which a first binding substance is immobilized, a water-absorbing substrate 2 containing a labeled second binding substance for adding a test liquid, and a developing buffer solution. It is essential to include the water absorbent base material 3 for impregnation. In addition, in the test piece of the present invention, it is essential that the water-absorbent substrate 1 and the water-absorbent substrate 3 are separately located at an interval such that they can be contact-crosslinked by the water-absorbent substrate 2. In the present specification, the water-absorbent substrate 1 refers to a water-absorbent substrate for immobilizing the first binding substance, and the water-absorbent substrate 2 is for adding a test liquid containing a labeled second binding substance. This refers to a water-absorbent substrate, and the water-absorbent substrate 3 is
A water-absorbent substrate for impregnating with a developing buffer solution.

【0011】吸水性基材1に固定化される第1結合物
質、吸水性基材2に含有される標識第2結合物質は、い
ずれも抗原抗体反応、リガンド−レセプター結合等の生
物学的親和性に基づいて被検物質と特異的に結合し得る
物質であれば特に制限はないが、抗原抗体反応により被
検物質と特異的に結合し得る物質(本明細書において
「免疫化学的成分」という。)が好ましい(以下、抗原
抗体反応に基づく第1結合物質を「第1免疫化学的成
分」、標識第2結合物質を「標識第2免疫化学的成分」
ともいう。)。例えば、被検物質が抗原(例えば、タン
パク質、ペプチド、ハプテンなど)であれば、第1免疫
化学的成分および標識第2免疫化学的成分は、該抗原と
特異的に結合しうる抗体である。該抗体はポリクローナ
ル抗体であってもモノクローナル抗体であってもよい。
また、本発明における抗体とは、被検物質との特異親和
性を保持する抗体の断片物、例えば、H鎖、L鎖、Fa
b、F(ab’)2、VH、VLなども含むものとする。
一方、被検物質が抗体である場合には、第1免疫化学的
成分および標識第2免疫化学的成分は、該抗体と特異的
に結合しうる抗原もしくは該抗体を抗原として特異的に
結合しうる二次抗体である。また、本発明における抗原
とは、被検抗体が認識して結合しうるエピトープ部分を
保持する抗原の断片物をも含むものとする。
The first binding substance immobilized on the water-absorbing substrate 1 and the labeled second binding substance contained on the water-absorbing substrate 2 are both biologically compatible with antigen-antibody reaction, ligand-receptor binding and the like. There is no particular limitation as long as it is a substance that can specifically bind to the test substance based on its sex, but a substance that can specifically bind to the test substance by an antigen-antibody reaction (herein, “immunochemical component”) Is preferred (hereinafter, the first binding substance based on the antigen-antibody reaction is the "first immunochemical component" and the labeled second binding substance is the "labeled second immunochemical component".
Also called. ). For example, when the test substance is an antigen (eg, protein, peptide, hapten, etc.), the first immunochemical component and the labeled second immunochemical component are antibodies that can specifically bind to the antigen. The antibody may be a polyclonal antibody or a monoclonal antibody.
The antibody in the present invention means an antibody fragment having a specific affinity with a test substance, such as H chain, L chain, Fa.
b, F (ab ′) 2 , V H , V L and the like are also included.
On the other hand, when the test substance is an antibody, the first immunochemical component and the labeled second immunochemical component bind to the antigen that can specifically bind to the antibody or specifically bind to the antibody as the antigen. Secondary antibody. In addition, the antigen in the present invention is meant to include an antigen fragment having an epitope portion that can be recognized and bound by a test antibody.

【0012】吸水性基材(吸水性基材1、吸水性基材
2、吸水性基材3)は、被検物質を含有する被検液なら
びに標識第2結合物質を含有する液を吸収できるもので
あれば特に限定はされない。本発明においては、被検液
中の被検物質が標識第2結合物質や固相部に固定化され
た第1結合物質と十分な反応を行うための時間を確保で
きるような吸水性基材が好ましく用いられる。
The water-absorbent substrate (water-absorbent substrate 1, water-absorbent substrate 2, water-absorbent substrate 3) can absorb the test liquid containing the test substance and the liquid containing the labeled second binding substance. There is no particular limitation as long as it is one. In the present invention, the water-absorbent substrate capable of ensuring a sufficient time for the test substance in the test liquid to sufficiently react with the labeled second binding substance and the first binding substance immobilized on the solid phase part. Is preferably used.

【0013】吸水性基材が吸水性に劣る場合には、被検
物質が固相部を通過するのに長時間を要し、その結果迅
速な測定を行うことができない。一方、吸水性基材の吸
水性が高すぎる場合には、被検液中の被検物質が標識第
2結合物質や固相部の第1結合物質と十分な反応を行う
ために必要な時間が不足するので正確な測定を行うこと
が困難である。
If the water-absorbent substrate is poor in water-absorbing property, it takes a long time for the test substance to pass through the solid phase portion, and as a result, rapid measurement cannot be performed. On the other hand, when the water absorbency of the water-absorbent substrate is too high, the time required for the test substance in the test liquid to sufficiently react with the labeled second binding substance and the first binding substance of the solid phase part It is difficult to make accurate measurements due to lack of

【0014】したがって、吸水性基材の好ましい吸水性
の程度は、例えば、5mm幅の短冊状に裁断した吸水性
基材の片端部を水に浸漬し、1分間経過後の吸水距離が
0.5〜5cm程度である。
Therefore, the preferable degree of water absorption of the water-absorbent substrate is, for example, that one end of the water-absorbent substrate cut into a strip shape having a width of 5 mm is immersed in water, and the water-absorption distance after one minute elapses from 0. It is about 5 to 5 cm.

【0015】吸水性基材の好ましい具体例としては、例
えば、不織布、ろ紙、ガラス繊維布、ガラスフィルタ
ー、ニトロセルロースフィルター(ニトロセルロースメ
ンブレン)、ナイロンなどの多孔質材料などが挙げられ
る。多孔質材料の孔径は、0.1〜15μmが例示さ
れ、1〜12μmが好ましい。また、吸水性基材の厚み
は0.05〜2mmが例示され、0.1〜1mmが好ま
しい。
Preferred specific examples of the water-absorbent substrate include, for example, non-woven fabric, filter paper, glass fiber cloth, glass filter, nitrocellulose filter (nitrocellulose membrane), and porous materials such as nylon. The pore size of the porous material is, for example, 0.1 to 15 μm, preferably 1 to 12 μm. The thickness of the water-absorbent substrate is, for example, 0.05 to 2 mm, preferably 0.1 to 1 mm.

【0016】また、これらの吸水性基材の吸水性を調整
するために、基材の表面に親水性重合体や界面活性剤を
被覆し、あるいは含浸させることもできる。さらに、吸
水性基材1、吸水性基材2、吸水性基材3として同一材
料からなる基材を用いてもよいし、あるいは異種の材料
からなるものを選択して用いることもできる。
Further, in order to adjust the water absorption of these water-absorbent substrates, the surface of the substrate may be coated with or impregnated with a hydrophilic polymer or a surfactant. Further, as the water-absorbent substrate 1, the water-absorbent substrate 2, and the water-absorbent substrate 3, substrates made of the same material may be used, or substrates made of different materials may be selected and used.

【0017】第1結合物質を吸水性基材1に固定化する
方法は、特に限定されるものではないが、従来から知ら
れている物理吸着法や共有結合法によるのが好適であ
る。吸水性基材1が共有結合法のための官能基を有さな
い場合は、例えば適当な官能基を有する重合体を用い
て、基材の吸水性を阻害しない程度に付着させることも
できる。また、第1結合物質および親水性重合体を含む
溶液を吸水性基材1に塗布した後に、該親水性重合体を
凝固させる凝固溶剤に浸漬することで固相部を作製する
こともできる。上記親水性重合体としては、例えば、ヒ
ドロキシプロピルメチルセルロース、ポリビニルアルコ
ール、ヒドロキシエチルセルロースなどを用いることが
できる。また、上記凝固溶剤としては、例えば、アセト
ン、エタノール、メタノール、エーテルなどを用いるこ
とができる。
The method for immobilizing the first binding substance on the water-absorbent substrate 1 is not particularly limited, but it is preferable to use the conventionally known physical adsorption method or covalent binding method. When the water-absorbent substrate 1 does not have a functional group for the covalent bonding method, for example, a polymer having an appropriate functional group may be used to attach the substrate to such an extent that the water-absorbing property of the substrate is not impaired. Alternatively, the solid phase part can be prepared by applying a solution containing the first binding substance and the hydrophilic polymer to the water-absorbent substrate 1 and then immersing the solution in a coagulating solvent for coagulating the hydrophilic polymer. As the hydrophilic polymer, for example, hydroxypropylmethyl cellulose, polyvinyl alcohol, hydroxyethyl cellulose or the like can be used. Further, as the coagulation solvent, for example, acetone, ethanol, methanol, ether or the like can be used.

【0018】吸水性基材1に固定化する第1結合物質の
量は、その物質の種類等によるが、通常、吸水性基材1
に1〜250μg/cm2である。
The amount of the first binding substance immobilized on the water-absorbent substrate 1 depends on the type of the substance and the like, but is usually the water-absorbent substrate 1.
It is 1 to 250 μg / cm 2 .

【0019】標識第2結合物質は、被検物質に特異的に
結合し得る物質に標識物質を結合させたものである。こ
こで用いられる標識物質は、化学的測定法において常套
的に使用されるいかなる標識物質であってもよく、例え
ば酵素(アルカリホスファターゼ、ペルオキシダーゼな
ど)、蛍光物質(FITC(イソチオシアン酸フルオレ
セイン)、ローダミンなど)、燐光物質、色素などが用
いられる。また、コロイド状金属、または酵素、蛍光物
質、燐光物質、色素などを結合もしくは含有させた水分
散性高分子が用いられる。
The labeled second binding substance is obtained by binding the labeling substance to a substance capable of specifically binding to the test substance. The labeling substance used here may be any labeling substance conventionally used in a chemical assay method, for example, an enzyme (alkaline phosphatase, peroxidase, etc.), a fluorescent substance (FITC (fluorescein isothiocyanate), rhodamine, etc.). ), Phosphors, dyes, etc. are used. In addition, a colloidal metal, or a water-dispersible polymer having an enzyme, a fluorescent substance, a phosphorescent substance, a dye or the like bound or contained therein is used.

【0020】本発明では、迅速な検出を行う意味で、標
識物質としてコロイド状金属、または、染料や顔料など
の色素で着色した水分散性高分子などの着色粒子が好ま
しく用いられる。コロイド状金属としては、例えば、
金、銀、銅などの金属からなるコロイドが挙げられる
が、金コロイドが好ましい。水分散性高分子を着色する
染料や顔料などの色素としては、例えば、スダンブルー
やオイルブルー、スダンレッドIV、スダンIII、オ
イルオレンジ、キニザリングリーン等が挙げられる。水
分散性高分子としては、例えば、ポリスチレンラテック
ス粒子、ポリメタクリル酸粒子などが挙げられる。
In the present invention, colored particles such as colloidal metal or water-dispersible polymer colored with a dye such as a dye or a pigment are preferably used as the labeling substance for the purpose of rapid detection. As the colloidal metal, for example,
Colloids composed of metals such as gold, silver and copper are mentioned, but gold colloids are preferable. Examples of dyes such as dyes and pigments for coloring the water-dispersible polymer include Sudan blue, oil blue, Sudan red IV, Sudan III, oil orange, and quinizarin green. Examples of the water-dispersible polymer include polystyrene latex particles and polymethacrylic acid particles.

【0021】コロイド状金属、着色粒子の平均粒子径
は、検出の際発色がよくかつ吸水性基材の吸水性を低下
させない程度の該基材中での移動度を有するものであれ
ば特に制限はないが、保存安定性や調製が容易であるな
どの点から、好ましくは0.01〜3μm、より好まし
くは0.05〜0.5μmの範囲が例示される。粒径が
あまりにも小さすぎると、1粒子あたりの着色の程度が
少ないので、固相部に結合しても発色の程度が低く、目
視確認性に欠ける。また、粒径が大きすぎると、コロイ
ド状金属、着色粒子が僅かに凝集しただけで吸水性基材
に目詰まりを生じて吸水性を低下させる、または非特異
的な発色を生じさせることがある。なお、本明細書にお
いて、平均粒子径は、レーザー回折・散乱型の粒子径分
布測定装置によって測定した。
The average particle size of the colloidal metal and the colored particles is particularly limited as long as the color development is good at the time of detection and the mobility in the water-absorbent substrate is not reduced. However, in view of storage stability and easy preparation, the range of 0.01 to 3 μm is preferable, and the range of 0.05 to 0.5 μm is more preferable. If the particle size is too small, the degree of coloring per particle is low, so that the degree of color development is low even when bound to the solid phase portion, and the visual confirmation property is poor. On the other hand, if the particle size is too large, the water-absorbent substrate may be clogged with a slight amount of colloidal metal or colored particles to reduce the water absorption, or non-specific coloring may occur. . In the present specification, the average particle size was measured by a laser diffraction / scattering type particle size distribution measuring device.

【0022】第2結合物質をこのような標識物質で標識
する方法としては、従来公知の方法、例えば共有結合
法、物理吸着法、イオン結合法などを使用することがで
きるが、免疫化学的成分等の第2結合物質からの標識物
質の脱離がなく安定であるという点から共有結合法がよ
り好ましく用いられる。
As a method for labeling the second binding substance with such a labeling substance, a conventionally known method, for example, a covalent binding method, a physical adsorption method, an ionic binding method or the like can be used. The covalent bond method is more preferably used because it is stable without desorption of the labeling substance from the second binding substance such as.

【0023】吸水性基材2に標識第2結合物質を含有さ
せる方法は特に限定されず従来公知の方法を使用するこ
とができる。例えば、標識第2結合物質の溶液を吸水性
基材2に塗布したのち、適当な条件にて乾燥固定化させ
る方法などである。乾燥の一様態として、吸水性基材に
塗布したのち、20〜60℃の風によって乾燥させる、
または凍結乾燥させることもできる。その他の方法とし
ては、水溶性重合体またはサッカロースの溶液中に標識
第2結合物質を分散させ、この分散液を吸水性基材2に
塗布したのち乾燥させる方法を挙げることができる。
The method of incorporating the labeled second binding substance into the water-absorbent substrate 2 is not particularly limited, and a conventionally known method can be used. For example, there is a method in which a solution of the labeled second binding substance is applied to the water-absorbent substrate 2 and then dried and immobilized under appropriate conditions. As a uniform state of drying, after applying to a water-absorbent substrate, it is dried by a wind of 20 to 60 ° C.,
Alternatively, it can be lyophilized. As another method, there can be mentioned a method in which the labeled second binding substance is dispersed in a solution of a water-soluble polymer or sucrose, and the dispersion is applied to the water-absorbent substrate 2 and then dried.

【0024】標識第2結合物質は吸水性基材2に乾燥固
定化して含有することが好ましい。吸水性基材2に乾燥
固定化した標識第2結合物質は、その吸水性基材に滴下
した被検液と接触させることにより吸水性基材から脱離
することができる。
The labeled second binding substance is preferably contained in the water-absorbent substrate 2 after being dried and immobilized. The labeled second binding substance dried and immobilized on the water-absorbent substrate 2 can be detached from the water-absorbent substrate by contacting the test liquid dropped on the water-absorbent substrate.

【0025】吸水性基材2の標識第2結合物質の含有量
は、その物質の種類等によるが、通常、吸水性基材2に
対して0.01〜2.5μgである。
The content of the labeled second binding substance in the water-absorbent substrate 2 depends on the type of the substance and the like, but is usually 0.01 to 2.5 μg with respect to the water-absorbent substrate 2.

【0026】検査片の形状は、吸水性基材3と吸水性基
材1を吸水性基材2で接触架橋した状態で被検液等を展
開できる形状であれば特に限定されず、例えば、短冊状
等が挙げられる。
The shape of the test piece is not particularly limited as long as the test liquid or the like can be spread in the state where the water-absorbent substrate 3 and the water-absorbent substrate 1 are contact-crosslinked with the water-absorbent substrate 2, and for example, Examples include strips.

【0027】検査片には吸水性基材1、吸水性基材2、
吸水性基材3に加えて他の部材を設けていてもよい。被
検液が血液、便懸濁液等の不溶性物質を含有する場合、
吸水性基材2には血球分離膜等の不溶物分離手段を設置
することが好ましい。血球分離膜としては、特に限定さ
れないが、市販されているもの(例えば、Spectral社製
SO904G/99D、日本ポール社製ヘマセップVなど)を使用
することもできる。このような血球分離膜を設置した吸
水性基材は、例えば、吸水性基材と血球分離膜とを任意
の手段にて貼り合わせるなどにより得ることができる。
The test piece includes a water-absorbent substrate 1, a water-absorbent substrate 2,
Other members may be provided in addition to the water absorbent substrate 3. When the test liquid contains insoluble substances such as blood and stool suspension,
The water-absorbent substrate 2 is preferably provided with insoluble matter separating means such as a blood cell separation membrane. The blood cell separation membrane is not particularly limited, but a commercially available one (for example, manufactured by Spectral)
SO904G / 99D, Hemarsep V manufactured by Nippon Pole, etc.) can also be used. The water-absorbent substrate provided with such a blood cell separation membrane can be obtained, for example, by bonding the water-absorbent substrate and the blood cell separation membrane by any means.

【0028】本発明の検査片を使用する検査方法は、標
識第2結合物質を含有した吸水性基材2に被検液を吸収
させた後、展開用緩衝液を含浸させた吸水性基材3と第
1結合物質を固定化した吸水性基材1を吸水性基材2で
接触架橋することにより行う。接触架橋により、被検液
と標識第2結合物質の混合液が検査片上で展開され、第
1結合物質の固定化された固相部を通過し複合体を形成
するので、この複合体の標識物質に由来するシグナルを
検出する。このような検査方法のうち、第1結合物質が
第1免疫化学的成分であり、標識第2結合物質が標識第
2免疫化学的成分である免疫クロマトグラフ法が好まし
い。
The test method using the test piece of the present invention is a water-absorbent substrate in which the test liquid is absorbed in the water-absorbent substrate 2 containing the labeled second binding substance and then impregnated with the developing buffer solution. This is performed by contact-crosslinking the water-absorbent substrate 1 on which 3 and the first binding substance are immobilized with the water-absorbent substrate 2. By the contact crosslinking, the mixed solution of the test liquid and the labeled second binding substance is developed on the test piece and passes through the solid phase portion on which the first binding substance is immobilized to form a complex. Detect the signal originating from the substance. Among such inspection methods, the immunochromatography method in which the first binding substance is the first immunochemical component and the labeled second binding substance is the labeled second immunochemical component is preferable.

【0029】展開用緩衝液は例えば、リン酸緩衝液、ホ
ウ酸緩衝液、Tris-HCl緩衝液等が挙げられる。吸水性基
材3に展開用緩衝液を含浸させる量は、被検物質などを
展開できる量であればよく、通常、吸水性基材3に対し
て30〜200μlであり、50〜150μlが好まし
い。
Examples of the developing buffer include phosphate buffer, borate buffer, Tris-HCl buffer and the like. The amount of the developing buffer solution impregnated into the water-absorbent substrate 3 may be any amount capable of developing the test substance and the like, and is usually 30 to 200 μl, and preferably 50 to 150 μl with respect to the water absorbent substrate 3. .

【0030】吸水性基材2への被検液の添加量は、吸水
性基材2を飽和させることができる量であり、吸水性基
材2の材質、大きさ等によるが、通常、吸水性基材2に
対して5〜50μlであり、10〜30μlが好まし
い。
The amount of the test liquid added to the water-absorbent substrate 2 is an amount capable of saturating the water-absorbent substrate 2 and depends on the material, size, etc. of the water-absorbent substrate 2. It is 5 to 50 μl, and preferably 10 to 30 μl with respect to the permeable substrate 2.

【0031】固相部の標識物質の検出は、標識物質が酵
素、蛍光物質、燐光物質の場合には、EIAや蛍光抗体
法(FIA)で従来使用されている検出手段が適宜選択
される。また、標識物質がコロイド状金属、着色粒子の
場合は分光光度計(例えばクロマトスキャナー(島津製
作所製、型番CS-900)など)やCCDカメラによる画像
解析等の手段を適宜選択すればよい。
For the detection of the labeling substance in the solid phase portion, when the labeling substance is an enzyme, a fluorescent substance, or a phosphorescent substance, the detection means conventionally used in EIA or the fluorescent antibody method (FIA) is appropriately selected. When the labeling substance is a colloidal metal or colored particles, a means such as a spectrophotometer (for example, a chromatoscanner (manufactured by Shimadzu Corporation, model number CS-900)) or an image analysis using a CCD camera may be appropriately selected.

【0032】[0032]

【実施例】以下、本発明を実施例により具体的に説明す
るが、本発明はこれらの実施例に限定されない。
EXAMPLES The present invention will now be described in detail with reference to examples, but the present invention is not limited to these examples.

【0033】実施例 C反応性蛋白(CRP)の検出 1)第1抗体(第1結合物質)固定化試験片の作製 ニトロセルロースメンブレン(孔径8μm、6mm×50mm)
(吸水性基材1)の一端から25mmの個所に抗ヒトCRP抗
体(DAKO社製、ウサギIgG、1mg/ml、0.1M-リン酸緩衝液
pH7.4)を1.5μl、ディスペンサーを用いてライン状に
塗布した。このメンブレンをウシ血清アルブミン(1重
量%)およびポリオキシエチレン(10)オクチルフェニ
ルエーテル(和光純薬工業社製、0.1重量%)からなる
水溶液中に10分間浸漬させた後、40℃で2時間乾燥させ
た。次いで、このメンブレンの裏側(抗体塗布面の反対
側)にポリエステルフィルム(100μm厚)を、スプレー
糊を用いて貼り合わせた。
Example C Detection of C-reactive protein (CRP) 1) Preparation of test piece with immobilized first antibody (first binding substance) Nitrocellulose membrane (pore size 8 μm, 6 mm × 50 mm)
An anti-human CRP antibody (DAKO, rabbit IgG, 1 mg / ml, 0.1 M-phosphate buffer solution) is placed 25 mm from one end of (water-absorbent substrate 1).
pH7.4) was applied in a line shape using 1.5 μl of a dispenser. This membrane was immersed in an aqueous solution consisting of bovine serum albumin (1% by weight) and polyoxyethylene (10) octylphenyl ether (manufactured by Wako Pure Chemical Industries, Ltd., 0.1% by weight) for 10 minutes and then at 40 ° C for 2 hours. Dried. Then, a polyester film (thickness of 100 μm) was attached to the back side of this membrane (the side opposite to the antibody-coated surface) using spray glue.

【0034】2)標識第2抗体(標識第2結合物質)の
作製 青色着色カルボキシル化ポリスチレンラテックス粒子分
散液(固形分濃度5重量%、平均粒子径0.1μm、0.01M-
ほう酸緩衝液pH8)3mlに、水溶性カルボジイミド(1mg/
ml、0.01M-ほう酸緩衝液pH8)1mlおよび抗ヒトCRP抗体
(DAKO社製、ウサギIgG、1mg/ml、0.01M-ほう酸緩衝液p
H8)1mlを加えて10℃で3時間反応させた後、洗浄液とし
てほう酸緩衝液(pH8)を用いて遠心分離洗浄を行い、
青色着色ラテックス粒子標識抗ヒトCRP抗体を作製し
た。次いで、ラテックス粒子標識抗体を0.01M-ほう酸緩
衝液(pH8)に、固形分濃度2重量%となるように懸濁し
た。
2) Preparation of labeled second antibody (labeled second binding substance) Blue colored carboxylated polystyrene latex particle dispersion (solid content concentration 5% by weight, average particle diameter 0.1 μm, 0.01 M-
Water-soluble carbodiimide (1mg / in 3ml of borate buffer pH8)
ml, 0.01 M-borate buffer pH 8) 1 ml and anti-human CRP antibody (DAKO, rabbit IgG, 1 mg / ml, 0.01 M-borate buffer p
H8) 1 ml was added and reacted at 10 ° C for 3 hours, followed by centrifugation and washing using a borate buffer (pH 8) as a washing solution,
A blue-colored latex particle-labeled anti-human CRP antibody was prepared. Next, the latex particle-labeled antibody was suspended in 0.01 M-borate buffer (pH 8) so that the solid content concentration was 2% by weight.

【0035】3)標識第2抗体を含有する被検液滴下用
試験片の作製 ニトロセルロースメンブレン(Whatman社製、孔径12μ
m、6mm×10mm)(吸水性基材2)にウシ血清アルブミン
(1重量%)およびポリオキシエチレン(10)オクチル
フェニルエーテル(和光純薬工業社製、0.1重量%)か
らなる水溶液中に10分間浸漬させた後、40℃で2時間乾
燥させた。次いで、上記2)で作製した標識第2抗体
を、終濃度0.1%となるように、サッカロース1%を含む
溶液中に分散させた液を、試験片の中央に1μlスポット
して、40℃で2時間乾燥して固定化させた。次いで、こ
のメンブレンの上面にポリエステルフィルム(25μm
厚)を、試験片の両端0〜3mmの個所にスプレー糊を用い
て貼り合わせた。さらに下面には、試験片の一端から2
〜8mmの個所にポリエステルフィルム(25μm厚)を貼り
合わせた。次いで、上面3〜7mmのメンブレンが露出した
個所にポリエステル不織布(6mm×4mm、厚さ2.5mm)を
設置し、標識第2抗体を含有する、被検液を滴下するた
めの部材を作製した。
3) Preparation of test sample for test liquid drop containing labeled secondary antibody Nitrocellulose membrane (Whatman, pore size 12 μm
m, 6 mm x 10 mm) (water-absorbent substrate 2) in an aqueous solution of bovine serum albumin (1% by weight) and polyoxyethylene (10) octylphenyl ether (manufactured by Wako Pure Chemical Industries, Ltd., 0.1% by weight) After soaking for 1 minute, it was dried at 40 ° C. for 2 hours. Next, the labeled secondary antibody prepared in 2) above was dispersed in a solution containing 1% sucrose so that the final concentration was 0.1%, and 1 μl of the solution was spotted on the center of the test piece at 40 ° C. It was dried for 2 hours and fixed. Then, a polyester film (25 μm
(Thickness) was adhered to the place of both ends 0 to 3 mm of the test piece by using a spray glue. Furthermore, on the bottom surface, 2
A polyester film (thickness of 25 μm) was attached to a place of ~ 8 mm. Then, a polyester non-woven fabric (6 mm × 4 mm, thickness 2.5 mm) was placed on the exposed surface of the membrane on the upper surface of 3 to 7 mm to prepare a member containing the labeled second antibody for dropping the test liquid.

【0036】4)展開用緩衝液含浸用試験片の作製 ニトロセルロースメンブレン(Whatman社製、孔径12μ
m、6mm×10mm)(吸水性基材3)にウシ血清アルブミン
(1重量%)およびポリオキシエチレン(10)オクチル
フェニルエーテル(和光純薬工業社製、0.1重量%)か
らなる水溶液中に10分間浸漬させた後、40℃で2時間乾
燥させた。次いで、このメンブレンの片面にポリエステ
ルフィルム(100μm厚)を、スプレー糊を用いて貼り合
わせた。このフィルムを貼り合わせた反対側の面に、試
験片の一端から0〜6mmの個所にポリエステル不織布(6m
m×6mm、厚さ2.5mm)を貼り合わせ、展開用緩衝液を含
浸させるための試験片を作製した。
4) Preparation of test piece for impregnation with buffer solution for deployment Nitrocellulose membrane (Whatman, pore size 12μ
m, 6 mm x 10 mm) (water-absorbent substrate 3) in an aqueous solution of bovine serum albumin (1% by weight) and polyoxyethylene (10) octylphenyl ether (manufactured by Wako Pure Chemical Industries, Ltd., 0.1% by weight) After soaking for 1 minute, it was dried at 40 ° C. for 2 hours. Next, a polyester film (100 μm thick) was attached to one side of this membrane using spray glue. On the opposite side of the film, the polyester non-woven fabric (6m
m × 6 mm, thickness 2.5 mm) were bonded to each other to prepare a test piece for impregnating with the developing buffer solution.

【0037】5)測定 上記1)、3)、4)で作製した試験片の部材を図1
(a)に示した形態に組み合わせ本発明の検査片とし、
図1(b)〜(d)の順に示したように測定した。0.1M
リン酸緩衝液(0.9重量%NaCl含有、pH7.4)に、被検試
料としてヒトCRP(日本バイオテスト社製)を任意の濃
度で溶解させた被検液を調製した。展開用緩衝液として
0.1Mリン酸緩衝液(0.9重量%NaCl含有、pH7.4)を、
4)で作製した試験片のポリエステル不織布部分に60μl
滴下して含浸させた。次いで、3)で作製した試験片部
材のポリエステル不織布に、各濃度の被検液を20μl滴
下して、下部の標識第2抗体が含有した吸水性基材に飽
和するまで吸収させ、乾燥固定した標識第2抗体を脱離
させて被検液と混合状態にさせた。次いで、6mmの間隔
で分離され配置されている、1)で作製した抗体固相部
を有する試験片と、4)で作製した展開用緩衝液を含有
する試験片を、上記の標識第2抗体と被検液の混合液を
含む試験片を用いて接触架橋する。接触により、抗体固
相部を有する試験片方向への液移動が開始され、被検液
と標識第2抗体の混合液が、第1抗体の固定化された固
相部を通過する際に複合体を形成し、標識物質に由来す
る検出シグナルを発生する。展開10分後、この検出シグ
ナルを、クロマトスキャナー(島津製作所製、型番CS-9
00)を用いて定量測定した。
5) Measurement The member of the test piece prepared in 1), 3) and 4) above is shown in FIG.
In combination with the form shown in (a), the test piece of the present invention,
The measurement was performed as shown in the order of FIGS. 0.1M
A test solution was prepared by dissolving human CRP (manufactured by Nippon Biotest Co., Ltd.) as a test sample at an arbitrary concentration in a phosphate buffer solution (containing 0.9% by weight NaCl, pH 7.4). As a developing buffer
0.1M phosphate buffer (containing 0.9 wt% NaCl, pH 7.4)
60μl on the polyester nonwoven fabric part of the test piece prepared in 4)
It was dripped and impregnated. Next, 20 μl of the test liquid of each concentration was dropped on the polyester non-woven fabric of the test piece member prepared in 3), absorbed by the water-absorbing base material containing the labeled second antibody at the bottom until it was saturated, and dried and fixed. The labeled second antibody was detached and mixed with the test solution. Next, the test piece having the antibody solid phase portion prepared in 1) and the test piece containing the developing buffer prepared in 4), which are separated and arranged at an interval of 6 mm, are attached to the labeled second antibody described above. And contact crosslinking using a test piece containing a mixture of the test liquid and the test liquid. Upon contact, liquid transfer to the direction of the test piece having the solid phase portion of the antibody is started, and when the mixed solution of the test liquid and the labeled second antibody passes through the solid phase portion on which the first antibody is immobilized, it is complexed. The body is formed and a detection signal derived from the labeling substance is generated. After 10 minutes of development, this detection signal was sent to a chromatoscanner (Shimadzu Corporation, model number CS-9
00) was used for quantitative measurement.

【0038】比較例 C反応性蛋白(CRP)の検出 1)第1抗体固定化試験片の作製 ニトロセルロースメンブレン(孔径8μm、6mm×60mm)
の上端から25mmの個所に抗ヒトCRP抗体(DAKO社製、ウ
サギIgG、1mg/ml、0.1M-リン酸緩衝液pH7.4)を1.5μ
l、ディスペンサーを用いてライン状に塗布した。この
メンブレンをウシ血清アルブミン(1重量%)およびポ
リオキシエチレン(10)オクチルフェニルエーテル(和
光純薬工業社製、0.1重量%)からなる水溶液中に10分
間浸漬させた後、40℃で2時間乾燥させた。次いで、こ
のメンブレンの裏側(抗体塗布面の反対側)にポリエス
テルフィルム(100μm厚)を、スプレー糊を用いて貼り
合わせた。
Comparative Example Detection of C-reactive protein (CRP) 1) Preparation of first antibody-immobilized test piece Nitrocellulose membrane (pore size 8 μm, 6 mm × 60 mm)
1.5μ of anti-human CRP antibody (DAKO, rabbit IgG, 1mg / ml, 0.1M-phosphate buffer pH7.4) at 25mm from the upper end of
l, was applied in a line using a dispenser. This membrane was immersed in an aqueous solution consisting of bovine serum albumin (1% by weight) and polyoxyethylene (10) octylphenyl ether (manufactured by Wako Pure Chemical Industries, Ltd., 0.1% by weight) for 10 minutes and then at 40 ° C for 2 hours. Dried. Then, a polyester film (thickness of 100 μm) was attached to the back side of the membrane (the side opposite to the antibody-coated surface) using a spray glue.

【0039】2)標識第2抗体の作製 青色着色カルボキシル化ポリスチレンラテックス粒子分
散液(固形分濃度5重量%、平均粒子径0.1μm、0.01M-
ほう酸緩衝液pH8)3mlに、水溶性カルボジイミド(1mg/
ml、0.01M-ほう酸緩衝液pH8)1mlおよび抗ヒトCRP抗体
(DAKO社製、ウサギIgG)1mg/ml、0.01M-ほう酸緩衝液p
H8)1mlを加えて10℃で3時間反応させた後、洗浄液とし
てほう酸緩衝液(pH8)を用いて遠心分離洗浄を行い、
青色着色ラテックス粒子標識抗ヒトCRP抗体を作製し
た。次いで、ラテックス粒子標識抗体を0.01M-ほう酸緩
衝液(pH8)に、固形分濃度2重量%となるように懸濁し
た。
2) Preparation of labeled secondary antibody Blue-colored carboxylated polystyrene latex particle dispersion (solid content concentration 5% by weight, average particle diameter 0.1 μm, 0.01 M-
Water-soluble carbodiimide (1mg / in 3ml of borate buffer pH8)
ml, 0.01 M-borate buffer pH8) 1 ml and anti-human CRP antibody (DAKO, rabbit IgG) 1 mg / ml, 0.01 M-borate buffer p
H8) 1 ml was added and reacted at 10 ° C for 3 hours, followed by centrifugation and washing using a borate buffer (pH 8) as a washing solution,
A blue-colored latex particle-labeled anti-human CRP antibody was prepared. Next, the latex particle-labeled antibody was suspended in 0.01 M-borate buffer (pH 8) so that the solid content concentration was 2% by weight.

【0040】3)標識第2抗体を含有する被検液滴下部
の作製 1)で作製した試験片の上端から50mmの部分に、上記2)
で作製した標識第2抗体を、終濃度0.1%となるよう
に、サッカロース1%を含む溶液中に分散させた液を1μ
lスポットして、40度で2時間乾燥させた。次いで、標識
第2抗体を固定化した個所(上端より47〜53mm)にポリ
エステル不織布(6mm×4mm、厚さ2.5mm)を設置し、被
検液滴下部を作製した。
3) Preparation of lower part of test liquid drop containing labeled second antibody In the part 50 mm from the upper end of the test piece prepared in 1), the above 2)
The labeled secondary antibody prepared in step 1 was dispersed in a solution containing 1% sucrose to a final concentration of 0.1%, and
It was spotted and dried at 40 degrees for 2 hours. Next, a polyester non-woven fabric (6 mm × 4 mm, thickness 2.5 mm) was placed at a location (47 to 53 mm from the upper end) where the labeled second antibody was immobilized, and a lower portion of the test liquid droplet was prepared.

【0041】4)展開用緩衝液滴下部の作製 3)で作製した試験片の下端部0〜6mmの個所にポリエス
テル不織布(6mm×6mm、厚さ2.5mm)を貼り合わせ、展
開用緩衝液滴下部を作製した。
4) Preparation of lower part of developing buffer droplets A polyester non-woven fabric (6 mm × 6 mm, thickness 2.5 mm) was attached to the lower end portion of the test piece prepared in 3) at a position of 0 to 6 mm, and Parts were produced.

【0042】5)測定 上記で作製した図2(a)に示した試験片を検査片とし
て用いて図2(b)〜(d)の順に示したように測定し
た。0.1Mリン酸緩衝液(0.9重量%NaCl含有、pH7.4)
に、被検試料としてヒトCRP(日本バイオテスト社製)
を任意の濃度で溶解させた被検液を調製した。3)で作
製した被検液滴下部のポリエステル不織布に、各濃度の
被検液を20μl滴下して、下部の標識第2抗体が含有し
た吸水性基材に吸収させ、乾燥固定した標識第2抗体を
脱離させて被検液と混合状態にさせた。次いで、展開用
緩衝液として0.1Mリン酸緩衝液(0.9重量%NaCl含有、p
H7.4)を、4)で作製した滴下部のポリエステル不織布
部分に60μl滴下して展開させた。被検液と標識第2抗
体の混合液が、第1抗体の固定化された固相部を通過す
る際に複合体を形成し、標識物質に由来する検出シグナ
ルを発生する。展開10分後、この検出シグナルを、クロ
マトスキャナー(島津製作所製、型番CS-900)を用いて
定量測定した。
5) Measurement Using the test piece shown in FIG. 2 (a) prepared above as an inspection piece, measurement was performed in the order shown in FIGS. 2 (b) to (d). 0.1M phosphate buffer (containing 0.9% by weight NaCl, pH 7.4)
In addition, human CRP (manufactured by Japan Biotest) as a test sample
A test liquid in which was dissolved at an arbitrary concentration was prepared. 20 μl of the test liquid of each concentration was dropped on the polyester nonwoven fabric under the test liquid droplet prepared in 3), and the water-absorbent substrate containing the labeled second antibody in the lower portion was absorbed and dried and fixed to the labeled second liquid. The antibody was released and mixed with the test solution. Then, 0.1M phosphate buffer (containing 0.9 wt% NaCl, p
60 μl of H7.4) was dropped onto the polyester non-woven fabric portion of the dropping portion prepared in 4) and developed. The mixed solution of the test liquid and the labeled second antibody forms a complex when passing through the solid phase portion on which the first antibody is immobilized, and generates a detection signal derived from the labeling substance. Ten minutes after development, this detection signal was quantitatively measured using a chromatoscanner (Shimadzu Corporation, model number CS-900).

【0043】結果(CVは変動係数を示す。) 実施例(n=10) CV10%以下 比較例(n=10) CV10%以上 実施例は定量測定値のばらつきが少なく高精度に対象被
検物質を検出することができた。
Results (CV indicates a coefficient of variation.) Example (n = 10) CV 10% or less Comparative example (n = 10) CV 10% or more In the example, there is little variation in quantitative measurement values and the target test substance is highly accurate. Was able to be detected.

【0044】[0044]

【発明の効果】本発明の検査片及び検査方法は、第1結
合物質を固定化した吸水性基材1と、展開用緩衝液を含
浸させた吸水性基材3とを分離して位置させ、被検液を
吸収させた、標識第2結合物質を含有した吸水性基材2
で吸水性基材1と吸水性基材3の間を接触架橋させるこ
とで、被検物質量に応じた検出シグナルを得ることがで
きる。すなわち、本発明の検査片は、標識第2結合物質
を含有する吸水性基材2に被検液を滴下し吸収させて飽
和した状態にすると、一定量の被検液を含むこととな
り、また、被検液と標識第2結合物質とが均一に混合し
た状態になる。この吸水性基材2により、第1結合物質
を固定化した吸水性基材1と展開用緩衝液を含浸させた
吸水性基材3との間を接触架橋すると、その時点で液移
動が開始し、被検液と標識第2結合物質は一定の混合状
態または濃度分布で吸水性基材1の固相部を通過して複
合体形成の反応を生じ、その結果、被検物質量に応じた
シグナルが高精度に得られる。
According to the test piece and the test method of the present invention, the water-absorbent substrate 1 on which the first binding substance is immobilized and the water-absorbent substrate 3 impregnated with the developing buffer are separated and positioned. A water-absorbent substrate 2 containing a labeled second binding substance, which has absorbed a test liquid
By contact-crosslinking between the water-absorbent substrate 1 and the water-absorbent substrate 3, the detection signal corresponding to the amount of the test substance can be obtained. That is, the test piece of the present invention contains a fixed amount of the test liquid when the test liquid is dropped onto the water-absorbent substrate 2 containing the labeled second binding substance to be absorbed and saturated, and Then, the test liquid and the labeled second binding substance are uniformly mixed. When the water-absorbing substrate 2 on which the first binding substance is immobilized and the water-absorbing substrate 3 impregnated with the developing buffer solution are contact-crosslinked by the water-absorbing substrate 2, liquid transfer starts at that point. Then, the test liquid and the labeled second binding substance pass through the solid phase portion of the water-absorbent substrate 1 in a constant mixed state or concentration distribution to cause a reaction for complex formation, and as a result, depending on the amount of the test substance. Signal can be obtained with high accuracy.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は、実施例の検査片の構成を示す断面図で
あって、展開する方向をみせている。
FIG. 1 is a cross-sectional view showing a structure of an inspection piece of an embodiment, showing a developing direction.

【図2】図2は、比較例の検査片の構成を示す断面図で
あって、展開する方向をみせている。
FIG. 2 is a cross-sectional view showing a configuration of a test piece of a comparative example, showing a developing direction.

【符号の説明】[Explanation of symbols]

1 吸水性基材1 2 吸水性基材2 3 吸水性基材3 1 Water-absorbent substrate 1 2 Water-absorbent substrate 2 3 Water-absorbent substrate 3

───────────────────────────────────────────────────── フロントページの続き (72)発明者 浅井 量子 大阪府茨木市下穂積1丁目1番2号 日東 電工株式会社内   ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Quantum Asai             1-2 1-2 Shimohozumi, Ibaraki City, Osaka Prefecture Nitto             Electric Works Co., Ltd.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 分離して位置する、被検物質と特異的に
結合し得る物質を固定化した吸水性基材1と展開用緩衝
液含浸用の吸水性基材3、および被検物質と特異的に結
合し得る標識された物質を含有した被検液添加用の吸水
性基材2を含有する検査片。
1. A water-absorbent substrate 1 on which a substance capable of specifically binding to a test substance is immobilized separately, a water-absorbent substrate 3 for impregnating a developing buffer, and a test substance. A test piece containing a water-absorbent substrate 2 for adding a test liquid containing a labeled substance capable of specifically binding.
【請求項2】 被検物質と特異的に結合し得る標識され
た物質の標識物質が色素で着色した水分散性高分子また
は金コロイドである、請求項1記載の検査片。
2. The test piece according to claim 1, wherein the labeling substance of the labeled substance capable of specifically binding to the test substance is a dye-colored water-dispersible polymer or gold colloid.
【請求項3】 吸水性基材2に被検物質と特異的に結合
し得る標識された物質が乾燥固定化した、請求項1また
は2に記載の検査片。
3. The test piece according to claim 1, wherein a labeled substance capable of specifically binding to a test substance is dry-immobilized on the water-absorbent substrate 2.
【請求項4】 吸水性基材2に血球分離膜を設置した、
請求項1〜3のいずれかに記載の検査片。
4. A blood cell separation membrane is provided on the water-absorbent substrate 2,
The test piece according to claim 1.
【請求項5】 被検物質と特異的に結合し得る物質が免
疫化学的成分であり、被検物質と特異的に結合し得る標
識された物質が標識された免疫化学的成分である、請求
項1〜4のいずれかに記載の検査片。
5. A substance capable of specifically binding to a test substance is an immunochemical component, and a labeled substance capable of specifically binding to a test substance is a labeled immunochemical component. Item 5. The inspection piece according to any one of Items 1 to 4.
【請求項6】 請求項1〜5のいずれかに記載の検査片
において、吸水性基材2に被検液を吸収させた後、展開
用緩衝液を含浸させた吸水性基材3と吸水性基材1を吸
水性基材2で接触架橋する、被検液中の被検物質の検査
方法。
6. The test piece according to any one of claims 1 to 5, wherein the water-absorbent substrate 2 is made to absorb a test liquid and then is impregnated with a developing buffer solution, and water-absorbent substrate 3. A method for inspecting a test substance in a test liquid, which comprises subjecting a hydrophilic substrate 1 to contact crosslinking with a water-absorbent substrate 2.
JP2002064188A 2002-03-08 2002-03-08 Inspection piece and inspection method Pending JP2003262637A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002064188A JP2003262637A (en) 2002-03-08 2002-03-08 Inspection piece and inspection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002064188A JP2003262637A (en) 2002-03-08 2002-03-08 Inspection piece and inspection method

Publications (1)

Publication Number Publication Date
JP2003262637A true JP2003262637A (en) 2003-09-19

Family

ID=29197100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002064188A Pending JP2003262637A (en) 2002-03-08 2002-03-08 Inspection piece and inspection method

Country Status (1)

Country Link
JP (1) JP2003262637A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006329900A (en) * 2005-05-30 2006-12-07 Hitachi Ltd Device and method for measuring biomolecular interaction
JP2012032263A (en) * 2010-07-30 2012-02-16 Kinki Univ Reagent for measuring immune containing fluorescent fine particle
JP2016090364A (en) * 2014-11-04 2016-05-23 日本写真印刷株式会社 Detection device and detection method

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006329900A (en) * 2005-05-30 2006-12-07 Hitachi Ltd Device and method for measuring biomolecular interaction
JP4640797B2 (en) * 2005-05-30 2011-03-02 株式会社日立製作所 Biomolecular interaction measuring apparatus and measuring method
JP2012032263A (en) * 2010-07-30 2012-02-16 Kinki Univ Reagent for measuring immune containing fluorescent fine particle
JP2016090364A (en) * 2014-11-04 2016-05-23 日本写真印刷株式会社 Detection device and detection method

Similar Documents

Publication Publication Date Title
US8859265B2 (en) Lateral flow immunoassay device with a more rapid and accurate test result
JP2977616B2 (en) Immunochemical test equipment
EP2376906A1 (en) Method for amplification of signal in immunochromatographic assay and immunochromatographic kit using the method
JP2010512537A (en) Indirect lateral flow sandwich assay
NO301193B1 (en) Test method and reagent kit for this
JPH06317595A (en) Complementary visual sense signal immunoassay
EP0564494B1 (en) Test method and reagent kit therefor
WO1987003690A1 (en) Particle-bound binding component immunoassay
WO2000002049A1 (en) Immunologic test method and immunologic test kit
JP2001033454A (en) Method and apparatus for determining substance to be detected on porous solid-phase ligand measuring test piece
JP4437211B2 (en) Measuring method using immunochromatography and sample analysis tool used therefor
JP3841559B2 (en) Immunological examination method and immunological examination kit
JP3930970B2 (en) Immunological examination method and immunological examination kit
JP2003262637A (en) Inspection piece and inspection method
JP2001228151A (en) Immunological chromatographic device
JP2001272405A (en) Examination kit
JP2002214236A (en) Method and device for detecting antigen in blood
JP2002328130A (en) Testing piece for immunological measurement method
JP3841558B2 (en) Immunological examination method and immunological examination kit
JP3841555B2 (en) Immunological examination method and immunological examination kit
JP2000028612A (en) Immunological inspection method and immunological inspection kit thereof
JP3930969B2 (en) Immunological examination method and immunological examination kit
JP3841556B2 (en) Immunological examination method and immunological examination kit
JP2001133455A (en) Test piece for immunochromatography
JP2002116203A (en) Test piece for detection of albumin in urine